Developer of immunomodulatory therapeutics designed for the treatment of acute inflammatory and rare diseases. ReAlta Life Sciences is based in Norfolk, VA. It was valued at $230 million at its later-stage round in Apr 2026, the last priced event on record. It has raised $155 million across 5 recorded rounds; the latest was a $25 million early-stage round in Dec 2024.
PMV mark · valuation
$230.0M
Oct 2026
Priced at
its later-stage round
Apr 2026
Total raised
$155.4M
Last round
Early Stage VC
Dec 2024
Team — not yet on record
No current team members for ReAlta Life Sciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ReAlta Life Sciences with a free account
·The complete investor list: 12 names
·Watch ReAlta Life Sciences: the Monday email on marks, rounds and moves
